Role of EBUS-TBNA in Mediastinal Staging of NSCLC Patients

Abstract

Purpose Mediastinal staging in non-small-cell lung carcinoma (NSCLC) is essential for appropriate treatment. Invasive mediastinal staging is necessary and mediastinoscopy has been the gold standard, but it is associated with morbidity. The aim of this study is to evaluate the efficacy of endobronchial ultrasonography transbronchial needle aspiration (EBUS-TBNA), compare it with mediastinoscopy, and assess the endosonographic features of lymph nodes for prediction of metastasis.

Methods This is a retrospective study of 200 patients with NSCLC who underwent EBUS-TBNA from January 2017 to December 2019. The patients with potentially resectable NSCLC who underwent EBUS-TBNA were included. Standard definitions of sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and diagnostic accuracy were used to determine the diagnostic performance of EBUS-TBNA.

Results A total of 200 patients and 616 nodes were studied, out of which 515 were benign and 101 were malignant. Out of 200 cases, 129 (64.5%) had <N2 disease, 59 (29.5%) had N2 disease, and 12 (6%) had N3 disease. EBUS-TBNA had a sensitivity of 78.87%, specificity of 96.12%, NPV of 89.2%, PPV of 91.8%, and accuracy of 90%. Ultrasonography (USG) features of 297 nodes were available and statistical significance was seen in rounded shape, size greater than 10 mm, ill-defined nodal margins, absence of hilum, and hypoechoic echotexture (p < 0.05).

Conclusion EBUS-TBNA is a safe and efficacious procedure for mediastinal sampling of NSCLC patients. Familiarity with endosonographic features of lymph nodes, which can predict malignancy in nodes, may further improve the yield of EBUS-TBNA and reduce under-staging.

Keywords

endobronchial ultrasound - FNA - non-small-cell lung cancer

Ethical Approval

The study was performed after approval from the Institutional Ethics Committee (IEC).

Publication History

Article published online:
06 March 2024

• References

• 1 De Leyn P, Dooms C, Kuzdzal J. et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014; 45 (05) 787-798
• 2 Gómez-Caro A, Garcia S, Reguart N. et al. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan. Eur J Cardiothorac Surg 2010; 37 (05) 1168-1174
• 3 Inage T, Nakajima T, Yoshino I. Staging lung cancer: role of endobronchial ultrasound. Lung Cancer (Auckl) 2014; 5: 67-72 PubMed
• 4 Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev 2014; 2014 (11) CD009519
• 5 Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008; 133 (04) 887-891
• 6 Vilmann P, Clementsen PF, Colella S. et al. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Endoscopy 2015; 47 (06) 545-559 Epub 2015 Jun 1. Erratum in: Endoscopy. 2015 Jun;47(6):c1. Vasquez-Sequeiros, Enrique [corrected to Vazquez-Sequeiros, Enrique]. PMID: 26030890
• 7 Keller S, Pearson FG, Cooper JD. et al. Mediastinal lymph node dissection. In: Ginsberg RJ, Hiebert CA, Patterson GA, Urschel HC. eds. Thoracic Surgery. 2nd ed. New York, NY: Churchill Livingstone;; 2002
• 8 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111 (06) 1718-1723
• 9 Dhooria S, Aggarwal AN, Gupta D, Behera D, Agarwal R. Utility and safety of endoscopic ultrasound with bronchoscope-guided fine-needle aspiration in mediastinal lymph node sampling: systematic review and meta-analysis. Respir Care 2015; 60 (07) 1040-1050
• 10 Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006; 61 (09) 795-798
• 11 Fernández-Bussy S, Labarca G, Canals S, Caviedes I, Folch E, Majid A. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging in lung cancer. J Bras Pneumol 2015; 41 (03) 219-224
• 12 Yasufuku K, Pierre A, Darling G. et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011; 142 (06) 1393-400.e1
• 13 Ahuja AT, Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol 2005; 184 (05) 1691-1699
• 14 Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45 (06) 474-479
• 15 Fujiwara T, Yasufuku K, Nakajima T. et al. The utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with lung cancer: a standard endobronchial ultrasound image classification system. Chest 2010; 138 (03) 641-647
• 16 Gogia P, Insaf TZ, McNulty W. et al. Endobronchial ultrasound: morphological predictors of benign disease. ERJ Open Res 2016; 2 (01) 00053-2015
• 17 Gill KR, Ghabril MS, Jamil LH. et al. Endosonographic features predictive of malignancy in mediastinal lymph nodes in patients with lung cancer. Gastrointest Endosc 2010; 72 (02) 265-271
• 18 Lee HS, Lee GK, Lee HS. et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?. Chest 2008; 134 (02) 368-374